Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Michael Verneris to Cell- and Tissue-Based Therapy

This is a "connection" page, showing publications Michael Verneris has written about Cell- and Tissue-Based Therapy.

 
Connection Strength
 
 
 
1.143
 
  1. Cobb LM, Verneris MR. Therapeutic manipulation of innate lymphoid cells. JCI Insight. 2021 03 22; 6(6).
    View in: PubMed
    Score: 0.633
  2. Verneris MR, Grupp SA. Natural killer cell consolidation for acute myelogenous leukemia: a cell therapy ready for prime time? J Clin Oncol. 2010 Feb 20; 28(6):909-10.
    View in: PubMed
    Score: 0.292
  3. Adams C, Keller M, Michlitsch JG, Aguayo-Hiraldo P, Chen K, Hossain MZ, Davis A, Park JR, Verneris MR, Gardner RA. Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy. Transplant Cell Ther. 2024 05; 30(5):475-487.
    View in: PubMed
    Score: 0.194
  4. Knorr DA, Bachanova V, Verneris MR, Miller JS. Clinical utility of natural killer cells in cancer therapy and transplantation. Semin Immunol. 2014 Apr; 26(2):161-72.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)